ALK-abello A/S Class B (AKBLF)
:AKBLF

ALK-abello (AKBLF) Similar Stocks

Compare
10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ALK-abello
$20.28
$4.47B
38.30
14.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
Dynavax
$12.71
$1.61B
74.24
1.03%
4 Buy
0 Hold
1 Sell
Moderate Buy
Inovio Pharmaceuticals
$1.50
$59.77M
-88.57%
1 Buy
2 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$1.48
$165.12M
17.46%
4 Buy
1 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$4.74
$264.08M
106.09%
1 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$109.61
$210.72B
18.84
17.80%
0 Buy
2 Hold
0 Sell
Hold
Bristol-Myers Squibb
$59.55
$122.13B
17.99%
5 Buy
10 Hold
1 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBLF
ALK-abello
20.48
2.80
15.84%
DVAX
Dynavax
12.71
0.40
3.25%
INO
Inovio Pharmaceuticals
1.50
-10.91
-87.91%
ACRS
Aclaris Therapeutics
1.48
0.26
21.31%
EBS
Emergent Biosolutions
4.74
2.58
119.44%
NVS
Novartis
109.61
17.98
19.62%
BMY
Bristol-Myers Squibb
59.55
9.32
18.55%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis